Vincristine Interactions
There are 490 drugs known to interact with vincristine, along with 8 disease interactions. Of the total drug interactions, 78 are major, 385 are moderate, and 27 are minor.
- View all 490 medications that may interact with vincristine
- View vincristine disease interactions (8)
Most frequently checked interactions
View interaction reports for vincristine and the medicines listed below.
- Adriamycin (doxorubicin)
- Ambien (zolpidem)
- Ativan (lorazepam)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Colace (docusate)
- Compazine (prochlorperazine)
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- Demerol (meperidine)
- Keppra (levetiracetam)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- MiraLAX (polyethylene glycol 3350)
- Neulasta (pegfilgrastim)
- Neupogen (filgrastim)
- Paracetamol (acetaminophen)
- Rituxan (rituximab)
- Tylenol (acetaminophen)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
- Zofran (ondansetron)
Vincristine disease interactions
There are 8 disease interactions with vincristine which include:
- pulmonary dysfunction
- neurologic dysfunction
- constipation
- hepatic dysfunction
- infections
- myelosuppression
- renal impairment
- SIADH
More about vincristine
- vincristine consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.